Accord announces that the CHMP has issued a positive opinion for Imuldosa® (development code: DMB-3115), a biosimilar to ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies ...

The two are improbable avatars of a campaign to restore America’s health, and some former Trump aides expressed skepticism ...

In a tough labor market where layoffs continue, some are considering—or even moving—from industry to academia, according to a ...

Alliance Global Partners has initiated coverage on Scilex Holding Company. The company explores strategic options for its subsidiary, Scilex Pharma, including potential spinoffs and dividend ...

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 trial of a combination shot for COVID-19 and influenza.

Shilpa Medicare's drug is presently undergoing a Phase 1A clinical trial to test its safety and how well it is tolerated in ...

Biodimension Technology Private Limited, a cutting-edge deep tech startup focused on human tissue and organ development, has ...

Neuropathic corneal pain (NCP) is listed in the National Organization for Rare Disorders (NORD) as an orphan diseaseOKYO is ...

Validated on the Illumina sequencer, the panel enables specific detection of over 6,500 DNA mutations in 61 clinically relevant genes, including those with matched targeted therapies currently ...

Tata Motors has once again secured 5 star rating in the BNCAP (Bharat New Car Assessment Program) crash test for its Nexon, and the newly launched Curvv, and Curvv.EV. This is not the first time that ...

Boeing is trying to shore up its struggling finances, to the tune of $35 billion. The aerospace giant is reeling from six ...